Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Short LLY ETF

8.57
0.0000
Volume:- -
Turnover:- -
Market Cap:1.54M
PE:- -
High:8.57
Open:8.57
Low:8.57
Close:8.57
52wk High:21.15
52wk Low:7.63
Shares:180.00K
Float Shares:180.00K
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

INNOVENT BIO Shares Climb Over 5% Again Following Seventh Global Partnership with Eli Lilly; Goldman Sachs Sees Undervaluation

Stock News
·
5 hours ago

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
9 hours ago

Top Midday Stories: Novo Nordisk Sues Hims for Alleged Patent Infringement; Transocean to Acquire Valaris for $5.8 Billion

MT Newswires Live
·
15 hours ago

BUZZ-Hims sinks to over-one-year low after Novo Nordisk patent‑infringement lawsuit

Reuters
·
Yesterday

Eli Lilly Shares Climb Over 3% on Acquisition of Immune Cell Engineering Firm Orna Therapeutics

Stock News
·
Yesterday

Eli Lilly To Rally More Than 21%? Here Are 10 Top Analyst Forecasts For Monday

Benzinga_recent_news
·
Yesterday

BRIEF-Lilly Q4 Adjusted EPS USD 7.54 Vs. IBES Estimate USD 6.67 (Feb. 4)

Reuters
·
Yesterday

Argus Adjusts Price Target on Eli Lilly and Company to $1,200 From $930, Maintains Buy Rating

MT Newswires Live
·
Yesterday

Eli Lilly Is Maintained at Buy by Deutsche Bank

Dow Jones
·
Yesterday

Eli Lilly : Argus Research Raises Target Price to $1200 From $930

THOMSON REUTERS
·
Yesterday

Corrected-Eli Lilly & Co. : Morgan Stanley Raises Target Price to $1,313 From $1290 (Not to $1290.00 From $24.20) (Feb 5)

THOMSON REUTERS
·
Yesterday

Eli Lilly to Buy Immune Cell Engineering Company Orna Therapeutics

MT Newswires Live
·
Yesterday

BRIEF-Lilly To Acquire Orna Therapeutics To Advance Cell Therapies

Reuters
·
Yesterday

Eli Lilly übernimmt Orna Therapeutics für bis zu 2,4 Milliarden Dollar

Reuters
·
Yesterday

Eli Lilly - Orna Shareholders to Receive up to $2.4 Bln in Cash

THOMSON REUTERS
·
Yesterday

Lilly to Acquire Orna Therapeutics to Advance Cell Therapies

THOMSON REUTERS
·
Yesterday

US STOCKS-Wall St futures muted as markets await key economic data

Reuters
·
Yesterday

Eli Lilly Shares up 2.2% Premarket After Hims & Hers Withdraws Launch of Weight-Loss Pill

THOMSON REUTERS
·
Yesterday

Strong Weight-Loss Drug Demand Fuels Optimistic Growth Outlook! Goldman Sachs Raises Eli Lilly Target to $1,260

Stock News
·
Yesterday

Bristol Gate Capital Partners Trims Eli Lilly Stake

TIPRANKS
·
Yesterday